Drugs / simeticone
last change Mar 2024 re-read 9 days ago

simeticone

Developed for
irritable bowel syndrome · constipation disorder · diarrheal disease
Investigated by
Laboratoires Mayoly Spindler · Alfasigma S.p.A. · Boehringer Ingelheim · McNeil AB

Trials 5

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 32 trials
Phase 3 NCT03106922 Apr 2016 → Jul 2020 — Alfasigma S.p.A. Unknown No outcome recorded
Phase 3 NCT02211976 Oct → Nov 2003 constipation disorder Boehringer Ingelheim Completed No outcome recorded
Phase 43 trials · 2 met primary
Phase 4 NCT01404923 Dec 2009 → Oct 2011 irritable bowel syndrome Laboratoires Mayoly Spindler Completed Met primary
Phase 4 NCT00807326 Nov 2008 → Aug 2009 diarrheal disease McNeil AB Completed Met primary
Phase 4 NCT00542295 Jul 2007 → Jul 2008 irritable bowel syndrome Laboratoires Mayoly Spindler Completed No outcome recorded
Comparator or background therapy1 trial
Phase 4 NCT06367452 Background Oct 2023 → Jan 2024 — Tecnoquimicas Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as simeticone “Sachet A: macrogol 4000 52.500 g, anhydrous sodium sulphate 3.750 g, simeticone 0.080 g;” NCT03106922 ↗
5

NCT00542295 ↗

NCT06367452 ↗

NCT01404923 ↗

NCT02211976 ↗

NCT00807326 ↗

Known as Asilone windcheaters ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗
Known as Infacol ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗
Known as Phazyme ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗
Known as Simeticona ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗
Known as Wind-eze ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗
Known as Windsetlers ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗
Route Oral “Oral, 2 caplets taken initially at investigator site followed by one caplet after each unformed stool” NCT00807326 ↗